Skip Nav Destination
Article Collection: Costs of Neurological Disorders
Costs of Neurological Disorders Article Collection brings you a selection of the latest and leading research that has been undertaken in various countries to describe the cost burden of various neurological conditions or the cost-effectiveness of new or augmented interventions to support policy decisions and clinical practice adoption.
This collection collates articles that have been specially invited by our Guest Editors Prof. Dominique Cadilhac (Monash University, Australia) and Prof. Ajay Mahal (The University of Melbourne, Australia) and further spontaneous contributions to Neuroepidemiology.
Conflict of Interest Statement: Prof. Ajay Mahal reports a grant from Edwards Life Sciences paid to his institution. Prof. Dominique Cadilhac has received the following industry grants paid to her institution over the last 3 years: Moleac, Boehringer Ingelhiem, Medtronic, Bristol-Myers Squibb, Amazon Web Services.
Image: burdun – stock.adobe.com
This collection collates articles that have been specially invited by our Guest Editors Prof. Dominique Cadilhac (Monash University, Australia) and Prof. Ajay Mahal (The University of Melbourne, Australia) and further spontaneous contributions to Neuroepidemiology.
Conflict of Interest Statement: Prof. Ajay Mahal reports a grant from Edwards Life Sciences paid to his institution. Prof. Dominique Cadilhac has received the following industry grants paid to her institution over the last 3 years: Moleac, Boehringer Ingelhiem, Medtronic, Bristol-Myers Squibb, Amazon Web Services.
Image: burdun – stock.adobe.com
